BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 10:57:00 AM | Browse: 1268 | Download: 1279
Publication Name World Journal of Dermatology
Manuscript ID 3906
Country/Territory Greece
Received
2013-06-01 09:44
Peer-Review Started
2013-06-01 22:56
To Make the First Decision
2013-06-09 09:55
Return for Revision
2013-06-18 16:06
Revised
2013-06-26 15:18
Second Decision
2013-07-05 12:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-07-05 13:20
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-07-11 19:24
Publish the Manuscript Online
2013-07-25 08:21
ISSN 2218-6190 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Dermatology
Manuscript Type Editorial
Article Title Adipocytokines and psoriasis: Insights into mechanisms linking obesity and inflammation to psoriasis
Manuscript Source Invited Manuscript
All Author List Maria Dalamaga and Evangelia Papadavid
Funding Agency and Grant Number
Corresponding Author Maria Dalamaga, MD, PhD, MS, MPH, Assistant Professor, Department of Clinical Biochemistry, Medical School, University of Athens, “Attikon” General University Hospital, Karyotaki 29, 15344 Athens, Greece. madalamaga@med.uoa.gr
Key Words Psoriasis; Adipocytokine; Obesity; Leptin; Adiponectin; Omentin; Resistin; Visfatin
Core Tip Adipocytokines could serve as a missing link in the association between psoriasis, obesity and metabolic co-morbidities. In chronic inflammatory disease states such as psoriasis, adipocytokines may be implicated in psoriasis onset, progression, severity as well as in the pathogenesis of co-morbidities. Measuring serum adipocytokine levels in the future may be useful in predicting psoriasis severity, progression, treatment outcome and risk of any co-morbidities. Interventions to decrease pro-inflammatory adipocytokine levels could offer preventive and therapeutic options for improving psoriasis severity and protecting against its co-morbidities. Candidate strategic interventions may incorporate increased physical activity, weight control and pharmacologic approaches such as metformin.
Publish Date 2013-07-25 08:21
Citation Dalamaga M, Papadavid E. Adipocytokines and psoriasis: Insights into mechanisms linking obesity and inflammation to psoriasis. World J Dermatol 2013; 2(4): 27-31
URL http://www.wjgnet.com/2218-6190/full/v2/i4/27.htm
DOI http://dx.doi.org/10.5314/wjd.v2.i4.27
Full Article (PDF) WJD-2-27.pdf
Manuscript File 3906-Review.docx
Answering Reviewers 3906-Answering reviewers.pdf
Biostatistics Review Certificate editorial and biostatistics.docx
Copyright License Agreement 3906-Copyright assignment.pdf
Institutional Review Board Approval Form or Document editorial and ethics committee.docx
Non-Native Speakers of English Editing Certificate 3906-Language certificate.pdf
Peer-review Report 3906-Peer reviews.pdf
Scientific Editor Work List 3906-Scientific editor work list.doc